Sage Therapeutics CFO, GC, CTO to depart in wide restructuring plan
CFO Dive
OCTOBER 17, 2024
The biotech will also be reducing its total workforce by approximately 33% and tapped its COO to take on responsibilities for finance as part of the restructuring.
Let's personalize your content